Mycophenolate mofetil Completed Phase 2 Trials for Liver Diseases / Transplantation, Liver Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00105235Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
NCT00693524Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX